How pharma markets disease to sell more drugs
The Real Truth About Health Free 17 Day Live Online Conference Podcast
00:00
Relative vs Absolute Risk in Statin Trials
Alan contrasts 42% relative reductions with 3.5% absolute benefit and how framing misleads clinicians.
Play episode from 09:01
Transcript
